Antonio Capaldi

907 total citations
20 papers, 663 citations indexed

About

Antonio Capaldi is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Antonio Capaldi has authored 20 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Hematology and 4 papers in Genetics. Recurrent topics in Antonio Capaldi's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Antonio Capaldi is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Antonio Capaldi collaborates with scholars based in Italy, United States and Sweden. Antonio Capaldi's co-authors include Massimo Aglietta, Mario Boccadoro, Giovannino Ciccone, Marco Montanaro, L. Lombardo, Francesca Gay, Patrizia Falco, Giulia Benevolo, Anna Marina Liberati and Pellegrino Musto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Leukocyte Biology.

In The Last Decade

Antonio Capaldi

19 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Capaldi Italy 12 397 332 261 121 56 20 663
Michele Wezeman United States 7 410 1.0× 319 1.0× 272 1.0× 130 1.1× 45 0.8× 9 691
Mariko Ishibashi Japan 13 322 0.8× 309 0.9× 297 1.1× 282 2.3× 37 0.7× 36 748
Jean‐Jacques Sotto France 17 410 1.0× 464 1.4× 406 1.6× 366 3.0× 54 1.0× 42 1.1k
Matteo Da Vià Italy 13 269 0.7× 388 1.2× 281 1.1× 88 0.7× 33 0.6× 34 738
S. Iacobelli Italy 11 255 0.6× 165 0.5× 300 1.1× 326 2.7× 40 0.7× 30 675
Maria Cristina Rapanotti Italy 14 163 0.4× 313 0.9× 171 0.7× 144 1.2× 32 0.6× 28 598
Emily Curran United States 16 201 0.5× 220 0.7× 278 1.1× 263 2.2× 27 0.5× 42 765
Robert H. Gersh United States 7 151 0.4× 206 0.6× 190 0.7× 37 0.3× 54 1.0× 8 501
Lori A. Ehrlich United States 9 465 1.2× 409 1.2× 302 1.2× 84 0.7× 14 0.3× 20 707
D. Huhn Germany 13 398 1.0× 184 0.6× 156 0.6× 366 3.0× 33 0.6× 25 765

Countries citing papers authored by Antonio Capaldi

Since Specialization
Citations

This map shows the geographic impact of Antonio Capaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Capaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Capaldi more than expected).

Fields of papers citing papers by Antonio Capaldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Capaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Capaldi. The network helps show where Antonio Capaldi may publish in the future.

Co-authorship network of co-authors of Antonio Capaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Capaldi. A scholar is included among the top collaborators of Antonio Capaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Capaldi. Antonio Capaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anselmetti, Giovanni Carlo, Antonio Manca, Filippo Montemurro, et al.. (2011). Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients. CardioVascular and Interventional Radiology. 35(1). 139–145. 45 indexed citations
2.
Palumbo, Antonio, Alessandra Larocca, Angelo Michele Carella, et al.. (2011). A Phase I/II Study of Pomalidomide-Cyclophosphamide-Prednisone (PCP) in Patients with Multiple Myeloma Relapsed/Refractory to Lenalidomide. Blood. 118(21). 632–632. 12 indexed citations
3.
Carnevale‐Schianca, Fabrizio, Susanna Gallo, Delia Rota‐Scalabrini, et al.. (2011). Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?. Journal of Clinical Oncology. 29(24). e691–e693. 37 indexed citations
4.
Aglietta, Massimo, Lisbeth Barkholt, Daniela Caravelli, et al.. (2009). Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience. Biology of Blood and Marrow Transplantation. 15(3). 326–335. 22 indexed citations
5.
Palumbo, Antonio, Sara Bringhen, Anna Marina Liberati, et al.. (2008). Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood. 112(8). 3107–3114. 250 indexed citations
6.
Sangiolo, Dario, Emanuela Martinuzzi, Maja Todorovic, et al.. (2008). Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers. International Immunology. 20(7). 841–848. 98 indexed citations
7.
Ortega, Claudia, Antonio Capaldi, S. Cirillo, et al.. (2007). Correlation of 11C-choline PET and PSA values in patients with prostate cancer and biochemical relapse after primary treatments. Journal of Clinical Oncology. 25(18_suppl). 5073–5073. 2 indexed citations
8.
Giaccone, Luisa, Benedetto Bruno, B Allione, et al.. (2006). LIMITED GRAFT-VERSUS MYELOMA EFFECT AFTER LOW-DOSE TBI BASED NON-MYELOABLATIVE ALLOGRAFTING EMPLOYED AS SALVAGE TREATMENT COMPARED TO FIRST LINE TREATMENT. 37.
9.
Grignani, Giovanni, et al.. (2006). Increase of creatine kinase value (CK) correlates with muscoloskeletal complaints (MSC) in GIST patients during imatinib therapy. Journal of Clinical Oncology. 24(18_suppl). 9509–9509. 2 indexed citations
10.
Carnevale‐Schianca, Fabrizio, Antonio Capaldi, Giovanni Grignani, et al.. (2005). Allogeneic Hemopoietic Stem Cell Transplantation in Solid Tumors. Transplantation Proceedings. 37(6). 2664–2666. 3 indexed citations
11.
Cignetti, Alessandro, Antonella Vallario, Antonia Follenzi, et al.. (2005). Lentiviral Transduction of Primary Myeloma Cells with CD80 and CD154 Generates Antimyeloma Effector T Cells. Human Gene Therapy. 16(4). 445–456. 5 indexed citations
12.
Montemurro, Filippo, R. Faggiuolo, Michela Donadio, et al.. (2004). A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer. Oncology. 66(1). 38–45. 36 indexed citations
13.
Montemurro, Filippo, R. Faggiuolo, Elisa Sperti, et al.. (2003). Safety and Activity of Docetaxel and Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer. American Journal of Clinical Oncology. 26(1). 95–97. 33 indexed citations
14.
Ballestrero, Alberto, Filippo Montemurro, Roberta Gonella, et al.. (2003). Dose-dense Vinorelbine and Paclitaxel with Granulocyte Colony-stimulating Factor in Metastatic Breast Cancer Patients: Anti-tumor Activity and Peripheral Blood Progenitor Cell Mobilization Capability. Breast Cancer Research and Treatment. 82(3). 185–190. 8 indexed citations
15.
Leone, Francesco, Eliana Perissinotto, Giuliana Cavalloni, et al.. (2003). Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells. Journal of Leukocyte Biology. 74(4). 593–601. 19 indexed citations
16.
Montemurro, Filippo, R. Faggiuolo, Elisa Sperti, et al.. (2003). . American Journal of Clinical Oncology. 26(1). 95–97. 2 indexed citations
17.
Leone, Francesco, Eliana Perissinotto, Andrea Viale, et al.. (2001). Detection of breast cancer cell contamination in leukapheresis product by real-time quantitative polymerase chain reaction. Bone Marrow Transplantation. 27(5). 517–523. 21 indexed citations
18.
Palumbo, Antonio, S Triolo, Luca Baldini, et al.. (2000). Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.. PubMed. 85(5). 508–13. 14 indexed citations
19.
Lombardo, L., et al.. (1995). Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. International Journal of Clinical & Laboratory Research. 25(3). 153–156. 51 indexed citations
20.
Saglio, Giuseppe, Clara Camaschella, Angelo Guerrasio, et al.. (1982). GΓ and AΓ globin chain synthesis in bone marrow and peripheral blood of β‐thalassaemia homozygotes. British Journal of Haematology. 52(2). 225–231. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026